Healthcare Realty Trust Incorporated Class A (HR)

Over the past six months, Healthcare Realty Trust's stock (HR) has shown an upward trend, increasing by 7.39%. Healthcare Realty Trust reported Q3 2025 EPS of -$0.17, missing forecasts, and revenue slightly below expectations, leading to a 1.38% stock decline post-announcement, however, operational metrics remained strong. In Q2 2025, the company reported a jump in FFO per share and strong same-store NOI growth. In Q1 2025, Healthcare Realty reported a solid start to the year with normalized FFO per share at $0.39 and same-store cash NOI growth of 2.3%. Healthcare Realty reaffirmed its full-year 2025 guidance and later raised its 2025 Normalized FFO per share outlook to a range of $1.57 to $1.61. The company maintained its dividend at $0.31 per share for Q1 2025. Healthcare Realty Trust entered into equity distribution agreements to establish a program on December 17, 2025. Healthcare Realty announced the appointment of Daniel Gabbay as EVP and CFO on January 7, 2026.

Demand for Healthcare Realty Trust's products and services, primarily the leasing of medical office buildings, is generally stable and not significantly impacted by traditional seasonality. This stability is driven by long-term demographic trends, such as an aging population, and the increasing shift towards outpatient care settings. Secular demand for outpatient medical space remains a key tailwind for the company, with demand often exceeding supply in top metropolitan areas. The essential nature of healthcare services ensures a consistent need for medical facilities throughout the year, mitigating pronounced seasonal fluctuations in demand.

Healthcare Realty Trust, Inc. (HR) is a real estate investment trust (REIT) focused on owning, managing, and developing outpatient medical office buildings (MOBs) across the United States. The company operates within the Real Estate sector, specifically in the Healthcare Facilities REIT and Specialized REIT industries. Its core business involves providing strategically located healthcare facilities that support healthcare providers in delivering patient care through leasing and management of medical office properties, fostering relationships with major hospital systems, academic medical centers, and physician groups. The company also engages in property acquisition and development to selectively grow its portfolio.

As of September 30, 2025, Healthcare Realty Trust was invested in 579 real estate properties across 28 states, encompassing a total of 33.6 million square feet. Its portfolio comprises approximately 17 million square feet of leasable space in 36 states, with a strong concentration in attractive, growth-oriented markets. The company strategically focuses on properties located adjacent to or on the campuses of major health systems, with 65% of its Net Operating Income (NOI) derived from its top 15 markets.

Healthcare Realty Trust maintains a generally stable brand reputation, supported by its focus on high-quality medical office buildings and strong relationships with healthcare providers. The company's operational performance, including robust demand for outpatient medical space, high tenant retention rates (nearly 89% in Q3 2025), and consistent same-store NOI growth, contributes positively to its reputation. Analyst ratings generally reflect a "Hold" consensus, with an average rating score of 2.20 based on 3 buy ratings, 6 hold ratings, and 1 sell rating. The company's strategic overhaul to become a pure-play Medical Office Building leader with a focus on operational excellence is a key ongoing development.

Healthcare Realty Trust's ownership structure is predominantly institutional. The company has 789 institutional owners and shareholders holding a total of 457,960,669 shares. Approximately 92.25% of the company's stock is owned by Institutional Investors, 0.57% by Insiders, and 7.18% by Public Companies and Individual Investors. Major institutional owners include Cohen & Steers, Inc., BlackRock, Inc., Vanguard Group Inc., State Street Corp, Price T Rowe Associates Inc /md/, Starboard Value LP, APG Asset Management US Inc., Invesco Ltd., and Daiwa Securities Group Inc.